Skip to content

Clinical trials

Observational Death, Sudden, Cardiac trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Death, Sudden, Cardiac Phase: Observational Clear all

213 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20022
20038
20042
20055
20062
20079
20087
20097
201012
20117
20128
201310
201410
20155
20168
20179
201813
20199
20205
202117
20224
202313
20246
202513
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed97
Unknown status53
Recruiting33
Active, not recruiting10
Terminated7
Not yet recruiting6
Enrolling by invitation5
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University College, London8
Johns Hopkins University6
National Heart, Lung, and Blood Institute (NHLBI)6
Zoll Medical Corporation5
Boston Scientific Corporation4
Heartstream US LLC3
Mayo Clinic3
Paris Sudden Death Expertise Center3
University Medical Center Goettingen3
University of Washington3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Death, Sudden, Cardiac213
Arrhythmias, Cardiac50
Heart Failure46
Heart Arrest34
Ventricular Fibrillation29
Cardiovascular Diseases28
Tachycardia, Ventricular28
Myocardial Infarction26
Cardiomyopathies21
Heart Diseases21

Trials

Showing 1 to 25 of 213. Each trial links to its page on Pharma Observatory.

113 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.